The CRO concept sector declined in the short term, with nearshore protein falling more than 8%, while Lanwei Medicine, Yiqiao Shenzhou, Lingkang Pharmaceutical, and Jinshi Ya Pharmaceutical followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.